These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 32932213

  • 1. Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients - A single centre experience.
    Dall'Olio FG, Conci N, Rossi G, Fiorentino M, De Giglio A, Grilli G, Altimari A, Gruppioni E, Filippini DM, Di Federico A, Nuvola G, Ardizzoni A.
    Lung Cancer; 2020 Nov; 149():5-9. PubMed ID: 32932213
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Economic analysis of BRAF gene mutation testing in real world practice using claims data: costs of single gene versus panel tests in patients with lung cancer.
    Dalal AA, Guerin A, Mutebi A, Culver KW.
    J Med Econ; 2018 Jul; 21(7):649-655. PubMed ID: 29516752
    [Abstract] [Full Text] [Related]

  • 5. Total cost of testing for genomic alterations associated with next-generation sequencing versus polymerase chain reaction testing strategies among patients with metastatic non-small cell lung cancer.
    Vanderpoel J, Stevens AL, Emond B, Lafeuille MH, Hilts A, Lefebvre P, Morrison L.
    J Med Econ; 2022 Jul; 25(1):457-468. PubMed ID: 35289703
    [Abstract] [Full Text] [Related]

  • 6. Comparison of targeted next-generation sequencing with conventional sequencing for predicting the responsiveness to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy in never-smokers with lung adenocarcinoma.
    Han JY, Kim SH, Lee YS, Lee SY, Hwang JA, Kim JY, Yoon SJ, Lee GK.
    Lung Cancer; 2014 Aug; 85(2):161-7. PubMed ID: 24857785
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Utility of multigene panel next-generation sequencing in routine clinical practice for identifying genomic alterations in newly diagnosed metastatic nonsmall cell lung cancer.
    Nindra U, Pal A, Bray V, Yip PY, Tognela A, Roberts TL, Becker TM, Williamson J, Farzin M, Li JJ, Lea V, Hagelamin A, Ng W, Wang B, Lee CS, Chua W.
    Intern Med J; 2024 Apr; 54(4):596-601. PubMed ID: 37713593
    [Abstract] [Full Text] [Related]

  • 9. Next-Generation Sequencing for Genotyping of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Samples in Lung Cancer.
    Xie F, Zheng X, Mao X, Zhao R, Ye J, Zhang Y, Sun J.
    Ann Thorac Surg; 2019 Jul; 108(1):219-226. PubMed ID: 30885850
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non-small-cell Lung Cancer: Implications of FISH-positive Patterns.
    Clavé S, Rodon N, Pijuan L, Díaz O, Lorenzo M, Rocha P, Taus Á, Blanco R, Bosch-Barrera J, Reguart N, de la Torre N, Oliveras G, Espinet B, Bellosillo B, Puig X, Arriola E, Salido M.
    Clin Lung Cancer; 2019 Jul; 20(4):e421-e429. PubMed ID: 30898567
    [Abstract] [Full Text] [Related]

  • 12. Budget impact analysis of next-generation sequencing versus sequential single-gene testing in Japanese patients with advanced non-small-cell lung cancer.
    Matsuda H, Ogawa T, Sadatsuki Y, Tsujino T, Wada S, Kim SW, Hatanaka Y.
    Respir Investig; 2023 Jan; 61(1):61-73. PubMed ID: 36460584
    [Abstract] [Full Text] [Related]

  • 13. Resistance Mechanisms to Targeted Therapies in ROS1+ and ALK+ Non-small Cell Lung Cancer.
    McCoach CE, Le AT, Gowan K, Jones K, Schubert L, Doak A, Estrada-Bernal A, Davies KD, Merrick DT, Bunn PA, Purcell WT, Dziadziuszko R, Varella-Garcia M, Aisner DL, Camidge DR, Doebele RC.
    Clin Cancer Res; 2018 Jul 15; 24(14):3334-3347. PubMed ID: 29636358
    [Abstract] [Full Text] [Related]

  • 14. Optimising fusion detection through sequential DNA and RNA molecular profiling of non-small cell lung cancer.
    Moore DA, Benafif S, Poskitt B, Argue S, Lee SM, Ahmad T, Papadatos-Pastos D, Jamal-Hanjani M, Bennett P, Forster MD.
    Lung Cancer; 2021 Nov 15; 161():55-59. PubMed ID: 34536732
    [Abstract] [Full Text] [Related]

  • 15. Gene rearrangement detection by next-generation sequencing in patients with non-small cell lung carcinoma.
    Brisudova A, Skarda J.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Jun 15; 164(2):127-132. PubMed ID: 32284620
    [Abstract] [Full Text] [Related]

  • 16. Prospective Clinical Integration of an Amplicon-Based Next-Generation Sequencing Method to Select Advanced Non-Small-Cell Lung Cancer Patients for Genotype-Tailored Treatments.
    Zugazagoitia J, Rueda D, Carrizo N, Enguita AB, Gómez-Sánchez D, Díaz-Serrano A, Jiménez E, Mérida A, Calero R, Lujan R, De Miguel E, Gámez P, Díaz-Hellín V, Nuñez JA, Iglesias L, Ferrer I, Paz-Ares L, Ponce-Aix S.
    Clin Lung Cancer; 2018 Jan 15; 19(1):65-73.e7. PubMed ID: 28780976
    [Abstract] [Full Text] [Related]

  • 17. Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May Benefit From Enrollment in Mechanism-Driven Clinical Trials.
    Suh JH, Johnson A, Albacker L, Wang K, Chmielecki J, Frampton G, Gay L, Elvin JA, Vergilio JA, Ali S, Miller VA, Stephens PJ, Ross JS.
    Oncologist; 2016 Jun 15; 21(6):684-91. PubMed ID: 27151654
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Optimizing Mutation and Fusion Detection in NSCLC by Sequential DNA and RNA Sequencing.
    Cohen D, Hondelink LM, Solleveld-Westerink N, Uljee SM, Ruano D, Cleton-Jansen AM, von der Thüsen JH, Ramai SRS, Postmus PE, Graadt van Roggen JF, Hoppe BPC, Clahsen PC, Maas KW, Ahsmann EJM, Ten Heuvel A, Smedts F, van Rossem RN, van Wezel T.
    J Thorac Oncol; 2020 Jun 15; 15(6):1000-1014. PubMed ID: 32014610
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.